PE20011005A1 - Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares - Google Patents

Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares

Info

Publication number
PE20011005A1
PE20011005A1 PE2000001168A PE0011682000A PE20011005A1 PE 20011005 A1 PE20011005 A1 PE 20011005A1 PE 2000001168 A PE2000001168 A PE 2000001168A PE 0011682000 A PE0011682000 A PE 0011682000A PE 20011005 A1 PE20011005 A1 PE 20011005A1
Authority
PE
Peru
Prior art keywords
phosphodiesterase
inhibitor
pulmonary diseases
inflammatory
combinations
Prior art date
Application number
PE2000001168A
Other languages
English (en)
Spanish (es)
Inventor
Peter N Goodfellow
Theodores J Torphy
Richard Nieman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PE20011005A1 publication Critical patent/PE20011005A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2000001168A 1999-11-02 2000-11-02 Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares PE20011005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
PE20011005A1 true PE20011005A1 (es) 2001-09-28

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001168A PE20011005A1 (es) 1999-11-02 2000-11-02 Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares

Country Status (29)

Country Link
EP (1) EP1225866A4 (fr)
JP (1) JP2003513028A (fr)
KR (1) KR20020057988A (fr)
CN (1) CN1387404A (fr)
AP (1) AP2002002496A0 (fr)
AR (1) AR029189A1 (fr)
AU (1) AU1357501A (fr)
BG (1) BG106748A (fr)
BR (1) BR0015270A (fr)
CA (1) CA2388333A1 (fr)
CO (1) CO5261512A1 (fr)
CZ (1) CZ20021512A3 (fr)
DZ (1) DZ3225A1 (fr)
EA (1) EA200200518A1 (fr)
EC (1) ECSP003747A (fr)
HK (1) HK1049107A1 (fr)
HU (1) HUP0203152A3 (fr)
IL (1) IL149367A0 (fr)
MA (1) MA26841A1 (fr)
MX (1) MXPA02004350A (fr)
NO (1) NO20022057L (fr)
OA (1) OA12076A (fr)
PE (1) PE20011005A1 (fr)
PL (1) PL355261A1 (fr)
SK (1) SK7592002A3 (fr)
TR (1) TR200201211T2 (fr)
TW (1) TWI242431B (fr)
WO (1) WO2001032127A2 (fr)
ZA (1) ZA200203435B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60218497T2 (de) 2001-09-19 2007-11-08 Nycomed Gmbh Kombination eines nsaids und eines pde-4 inhibitors
WO2003037349A1 (fr) * 2001-10-31 2003-05-08 Merck Patent Gmbh Inhibiteurs de la phosphodiesterase de type 4 et leurs utilisations
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (fr) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Composition therapeutique
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (fr) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Traitements prophylactiques ou therapeutiques de maladie chronique de la peau
JP2009512677A (ja) * 2005-10-19 2009-03-26 ランバクシー ラボラトリーズ リミテッド ホスホジエステラーゼタイプｉｖ阻害剤の組成物
CN105381524A (zh) 2010-01-05 2016-03-09 微剂量治疗技术公司 吸入设备和方法
WO2015063669A1 (fr) 2013-10-30 2015-05-07 Wockhardt Limited Compositions pharmaceutiques comprenant une combinaison de roflumilast et d'acébrophylline ou de leurs sels pharmaceutiquement acceptables

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710109B1 (fr) * 1993-06-18 2004-09-15 Smithkline Beecham Corporation Méthode d'identification d'un inhibiteur de la PDE IV
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
EP1225866A4 (fr) 2004-04-21
CO5261512A1 (es) 2003-03-31
NO20022057D0 (no) 2002-04-30
MXPA02004350A (es) 2002-11-07
AP2002002496A0 (en) 2002-06-30
WO2001032127A3 (fr) 2001-12-06
MA26841A1 (fr) 2004-12-20
TR200201211T2 (tr) 2002-08-21
CN1387404A (zh) 2002-12-25
ECSP003747A (es) 2002-05-23
NO20022057L (no) 2002-06-27
WO2001032127A2 (fr) 2001-05-10
AR029189A1 (es) 2003-06-18
AU1357501A (en) 2001-05-14
HK1049107A1 (zh) 2003-05-02
KR20020057988A (ko) 2002-07-12
EP1225866A2 (fr) 2002-07-31
JP2003513028A (ja) 2003-04-08
HUP0203152A3 (en) 2004-06-28
BR0015270A (pt) 2002-06-18
HUP0203152A2 (hu) 2003-01-28
ZA200203435B (en) 2003-06-25
CZ20021512A3 (cs) 2003-04-16
OA12076A (en) 2006-05-04
DZ3225A1 (fr) 2001-05-10
TWI242431B (en) 2005-11-01
SK7592002A3 (en) 2002-11-06
BG106748A (en) 2003-02-28
PL355261A1 (en) 2004-04-05
IL149367A0 (en) 2002-11-10
CA2388333A1 (fr) 2001-05-10
EA200200518A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
AR032471A1 (es) Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
UY26977A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos
CO5140098A1 (es) Combinaciones de un agonista de betra-2 y un esteroide, su uso para tratamiento de enfermedades inflamatorias u obstructivas de las vias aereas
IT1320176B1 (it) Dispersioni solide di principi attivi nitrati.
WO2008057420A3 (fr) Dérivés de triterpène étendus
ES2152222T3 (es) Sulfonamidas, su preparacion y su uso como medicamento e intermedio.
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
CY1108453T1 (el) Διαδικασια για την παρασκευη επλερενονης
CL2004001170A1 (es) Combinacion farmaceutica inhalable que contiene (a) formoterol, o una sal, o un solvato de el o de la sal y (b) furoato de mometasona; estuche farmaceutico que la comprende; y su uso en la terapia de una enfermedad inflamatoria u obstructiva de las v
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
PE20011005A1 (es) Combinaciones de un inhibidor de fosfodiesterasa 4 y un antiinflamatorio esteroideo para el tratamiento de las enfermedades pulmonares
ES2152670T3 (es) Derivados de nitrito y nitrato esteroideos utiles como farmacos antiinflamatorios.
ES2188426B1 (es) Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
DE50312034D1 (de) Liposomale glucocorticoide
CL2011003144A1 (es) Forma cristalina e3 de bisulfato de atazanavir; composicion farmaceutica que la comprende; util para el tratamiento de enfermedades originadas por retrovirus (divisional de la solicitud 1057-05).
PE20020348A1 (es) Exemestano como agente quimiopreventivo
CR6824A (es) Derivados de arilmetilamina para uso como inhibidores de triptasa
DK0912185T3 (da) Nye farmaceutiske sammensætninger indeholdende steroidnitratesterderivater, der kan anvendes som antiinflammatoriske lægemidler
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
RU2007138263A (ru) Противовоспалительные соединения
PE20020793A1 (es) Agente preventivo y/o terapeutico de enfermedades inflamatorias del tracto respiratorio
ES2180690T3 (es) Preparacion de composiciones que comprenden st1435 para aplicacion topica.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal